Breaking down the latest scientific discoveries in longevity medicine.
All Papers
40 papers
Inflammation & Immune Health
Inflammaging: Experimental Insights and Translational Advances
European Journal of Immunology · 2026 · Cossarizza A et al.
Modern longevity science is moving from understanding immune aging to actively reversing it. This state-of-the-art study details how novel clinical interventions can calm overactive inflammatory pathways and reboot immune cell function. Utilizing targeted therapies to restore immune balance helps protect the body against infections, chronic diseases, and systemic decline as we age.
BPC-157 as an Investigational Peptide Therapeutic: Biopharmaceutical Challenges, Formulation Strategies, and Translational Development Barriers
Pharmaceutics · 2026 · Mateescu DM et al.
BPC-157 is a therapeutic peptide derived from a protein naturally found in human gastric juice that plays a vital role in protecting and repairing tissues. Research shows that it promotes blood vessel growth, speeds up tendon and joint recovery, and helps heal the gut lining. Understanding these cellular repair mechanisms allows clinicians to leverage peptide therapies for faster recovery from injuries and improved gut health.
Randomized phase 2b dose-escalation trial of stem cell therapy with laromestrocel for aging frailty
Cell Stem Cell · 2026 · Ruiz JG et al.
Aging frailty is characterized by chronic inflammation, loss of muscle stamina, and reduced stem cell activity throughout the body. In this rigorous phase 2b clinical trial, receiving intravenous stem cell therapy led to significant improvements in walking distance, physical endurance, and mental clarity in older adults. Stem cell therapy helps rebuild the body's regenerative capacity, reducing age-related frailty from the cellular level up.
Plasma-based strategies for systemic rejuvenation: critical perspectives on clinical translation
GeroScience · 2026 · Gulej R et al.
Therapeutic plasma exchange is rapidly emerging as one of the most exciting clinical tools in longevity medicine. This updated comprehensive review outlines the exact clinical standards, safety guidelines, and monitoring metrics used to perform plasma filtration procedures safely. By establishing rigorous clinical standards, plasma exchange can be seamlessly integrated into comprehensive anti-aging programs.
Extracellular vesicles from antler blastema progenitor cells reverse bone loss and mitigate aging-related phenotypes
Nature Aging · 2025 · Hao Y et al.
Exosomes are tiny membrane bubbles released by stem cells that carry biological instructions, growth factors, and genetic signals to surrounding tissues. This study showed that specialized stem cell exosomes could effectively reverse age-related bone loss and systemic tissue aging in advanced models. Cell-free exosome therapies represent one of the safest and most targeted approaches to cellular rejuvenation available today.
Effects of intermittent senolytic therapy on bone metabolism in postmenopausal women: a phase 2 RCT
Nature Medicine · 2024 · Farr JN et al.
Bone density naturally declines with age because senescent cells build up inside bone tissue, disrupting normal repair processes. This Phase 2 study demonstrated that periodic, short-term senolytic therapy lowered senescent cell burden and stimulated new bone formation. This approach offers a novel way to preserve bone strength and prevent age-related fractures.
Diagnostic Accuracy of a Plasma Phosphorylated Tau 217 Immunoassay for Alzheimer Disease Pathology
JAMA Neurology · 2024 · Ashton NJ et al.
Detecting Alzheimer's pathology traditionally required invasive spinal taps or expensive brain scans. This 2024 study validated a revolutionary blood test measuring 'p-tau217' that detects silent neurodegenerative changes with up to 97% accuracy. This breakthrough allows doctors to assess brain health during routine checkups long before memory symptoms ever begin.
Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission
The Lancet · 2024 · Livingston G et al.
The global Lancet Commission on dementia revealed that up to 45% of cognitive decline cases can be prevented by addressing 14 specific lifestyle and health factors. Key protective steps include managing LDL cholesterol, protecting your hearing and vision, staying physically active, and maintaining metabolic health. Proactive lifestyle modifications remain one of your most powerful tools for lifelong cognitive vitality.
Testosterone Treatment and Fractures in Men with Hypogonadism
NEJM · 2024 · Snyder PJ et al.
Age-related testosterone loss is directly tied to muscle wasting and thinning bones. Clinical data from the TRAVERSE fracture study shows that testosterone replacement improves bone architecture and volumetric density in men with low hormone levels. Pairing hormone therapy with strength training provides a well-rounded strategy for skeletal longevity.
The Women's Health Initiative Randomized Trials and Clinical Practice: A Review
JAMA · 2024 · Manson JE et al.
A comprehensive 20-year review published in JAMA clarified longstanding misconceptions about Menopausal Hormone Therapy (MHT). When started under age 60 or within 10 years of menopause, MHT is safe and offers significant long-term protection—reducing bone fractures, lowering diabetes risk, and decreasing overall mortality. Custom hormone therapy can safely enhance quality of life and long-term health during menopause.
Donanemab in Early Symptomatic Alzheimer Disease: TRAILBLAZER-ALZ 2
JAMA · 2023 · Sims JR et al.
Donanemab is an advanced antibody designed to eliminate plaque buildup in brain tissue. Results from the TRAILBLAZER-ALZ 2 trial revealed that patients treated at earlier stages of brain aging experienced a 35% slowing in cognitive decline. In fact, nearly half of the treated patients showed no disease progression at all during the first year of treatment.
Scientists have identified 12 key processes inside our cells—known as the "Hallmarks of Aging"—that cause our bodies to decline over time. Rather than viewing diseases like heart disease or memory loss as separate issues, this research shows that they all stem from these shared cellular drivers. By identifying these root mechanisms, modern longevity medicine can target the primary causes of aging to keep you healthier and more vibrant for longer.
Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes
NEJM · 2023 · Lincoff AM et al.
GLP-1 medications do far more than just assist with weight management; they directly shield your cardiovascular system. This major international study showed that semaglutide reduced the risk of heart attacks, strokes, and cardiovascular death by 20% in people without diabetes. These findings highlight how optimizing metabolic health directly protects your heart as you age.
Cardiovascular Safety of Testosterone-Replacement Therapy
NEJM · 2023 · Lincoff AM et al.
For years, questions lingered regarding whether testosterone therapy affected heart health in aging men. The landmark TRAVERSE trial followed over 5,000 men and proved that properly prescribed testosterone replacement does not increase the risk of heart attacks or strokes. This research confirms that hormone optimization can be safely managed to support energy, muscle strength, and metabolic vitality.
Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients
NEJM · 2023 · Nissen SE et al.
Many patients struggle to take statin medications due to muscle aches or weakness. The CLEAR Outcomes trial evaluated bempedoic acid, an oral medication that selectively targets cholesterol synthesis in the liver without affecting muscle tissue. The drug lowered LDL cholesterol by over 20%, reduced blood vessel inflammation, and cut major heart events by 13%.
Triple-Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial
NEJM · 2023 · Jastreboff AM et al.
Scientists have developed a single compound called retatrutide that targets three distinct metabolic hormone receptors at once. In clinical trials, this triple-action therapy helped patients achieve unprecedented weight loss—up to 24% of total body weight—while clearing fatty liver deposits. This multi-pathway approach targets metabolic decline at its source.
For decades, slowing the progression of memory decline was a major challenge in medicine. This landmark trial showed that lecanemab, a therapy designed to clear toxic amyloid protein buildup from the brain, slowed cognitive decline by 27% in early-stage patients over 18 months. These results prove that catching and treating brain changes early can help preserve cognitive independence.
Association of Apolipoprotein B-Containing Lipoproteins and Risk of Myocardial Infarction
JAMA Cardiology · 2022 · Marston NA et al.
Standard cholesterol panels measure the weight of cholesterol carried in your blood, but it is actually the number of lipid-carrying particles (measured by ApoB) that penetrate artery walls to cause blockages. This major study in JAMA Cardiology proved that ApoB is a superior predictor of heart attack risk compared to traditional LDL cholesterol. Tracking ApoB gives us a clearer picture for preventing arterial plaque buildup.
Cardiorespiratory Fitness and Mortality Risk Across the Spectra of Age, Race, and Sex
J Am Coll Cardiol · 2022 · Kokkinos P et al.
Regardless of your age, gender, or starting fitness level, boosting your cardiovascular endurance delivers dramatic survival advantages. Analyzing three-quarters of a million people, scientists found that moving out of the lowest fitness category reduced death risk by roughly half. This confirms that starting a personalized, progressive exercise routine at any point in life pays immediate and lasting health dividends.
Small Interfering RNA to Reduce Lipoprotein(a) in Cardiovascular Disease
NEJM · 2022 · O'Donoghue ML et al.
Lipoprotein(a), or Lp(a), is a genetically inherited variant of cholesterol affecting 1 in 5 people that cannot be controlled through diet, exercise, or standard statins. This study published in NEJM evaluated olpasiran, a gene-silencing RNA therapy that reduced toxic Lp(a) levels by more than 95%. This therapeutic advance targets inherited cardiovascular risks that were once untreatable.
Old plasma dilution reduces human biological age: a clinical study
GeroScience · 2022 · Kim D et al.
As we age, our blood plasma accumulates inflammatory proteins, cellular debris, and circulating factors that accelerate organ decline. This human clinical study showed that therapeutic plasma exchange—a process that filters out old plasma and replaces it with pure albumin—effectively resets key biological age clocks and reduces systemic inflammation. Diluting old plasma creates a younger, cleaner internal environment that supports organ health and cellular rejuvenation.
Tirzepatide Once Weekly for the Treatment of Obesity
NEJM · 2022 · Jastreboff AM et al.
Excess weight and metabolic imbalance are major drivers of premature aging and chronic disease. In this landmark study, a once-weekly dual-hormone medication called tirzepatide helped adults lose over 20% of their total body weight on average. In addition to dramatic weight reduction, patients experienced significant improvements in blood sugar, cholesterol, and blood pressure levels.
Muscle-strengthening activities and risk of major non-communicable diseases: systematic review and meta-analysis
British Journal of Sports Medicine · 2022 · Momma H et al.
While cardio exercises get a lot of attention, lifting weights and building strength are equally critical for long-term survival and health. This comprehensive study showed that engaging in just 30 to 60 minutes of strength training each week reduces overall risk of death and chronic disease by up to 17%. When resistance training is combined with aerobic exercise, overall mortality risk drops by an astounding 40%.
An aged immune system drives senescence and ageing of solid organs
Cell · 2021 · Yousefzadeh MJ et al.
Scientists long wondered whether organs age independently or if one master system triggers body-wide decline. This study published in Cell proved that an aging, dysfunctional immune system actively drives premature aging in other solid organs like the heart, liver, and kidneys. Maintaining a resilient, youthful immune system protects every organ in your body from accelerated wear and tear.
Once-Weekly Semaglutide in Adults with Overweight or Obesity
NEJM · 2021 · Wilding JPH et al.
Carrying extra visceral fat around vital organs drives systemic inflammation and accelerates aging. The STEP 1 trial demonstrated that weekly semaglutide enabled participants to lose nearly 15% of their body weight while significantly narrowing waist circumference. Furthermore, key markers of internal inflammation and blood sugar control improved across the board.
Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women
Science · 2021 · Yoshino M et al.
NAD+ is a critical molecule that fuels energy production in every cell, but its levels drop dramatically as we age. This rigorous human study found that daily supplementation with NMN, an NAD+ building block, significantly improved muscle insulin sensitivity in prediabetic women. By restoring cellular energy pathways, NAD+ boosting helps your muscles efficiently absorb glucose and stay metabolically youthful.
MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis
Nature Communications · 2021 · Reynolds JC et al.
Mitochondria are best known as the cellular powerhouses that produce energy, but researchers have discovered they also release special messenger peptides like MOTS-c. This study showed that MOTS-c mimics the metabolic and physical performance benefits of intense physical exercise, preserving muscle strength and metabolic health as we age. For patients looking to maintain vitality, mitochondrial peptide therapies represent an exciting frontier in cellular energy restoration and healthy aging.
Rejuvenation of three germ layers tissues by exchanging old blood plasma with saline-albumin
Aging · 2020 · Mehdipour M et al.
For years, scientists debated whether young blood contained special rejuvenation factors or if old blood simply accumulated toxic signals that suppress healing. This groundbreaking research proved that simply removing old, inhibitory plasma and replacing it with a neutral saline-albumin solution triggered widespread tissue repair across the brain, liver, and muscle. Clearing out circulating cellular debris allows your body's native stem cells to repair tissue properly.
A randomized, controlled clinical trial of plasma exchange with albumin replacement for Alzheimer's disease: AMBAR Study
Alzheimer's & Dementia · 2020 · Boada M et al.
The AMBAR study was a major clinical trial examining whether clearing toxic proteins from the bloodstream could slow down brain aging and memory loss. The results demonstrated that regular therapeutic plasma exchange slowed the progression of cognitive decline in Alzheimer's patients by up to 61%. This proves that removing harmful factors from circulation protects brain cells and preserves cognitive function as we age.
Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease
EBioMedicine · 2019 · Hickson LJ et al.
As we age, some of our cells stop dividing but refuse to die, lingering as harmful "zombie cells" that secrete inflammatory toxins into surrounding tissues. This historic human trial proved that a targeted senolytic therapy could safely and selectively target and clear these senescent cells from human body tissue. Removing these damaged cells reduces systemic inflammation and allows healthy tissue regeneration.
Reversal of epigenetic aging and immunosenescent trends in humans
Aging Cell · 2019 · Fahy GM et al.
Can we actually turn back our cellular clock? The pioneering TRIIM clinical study demonstrated that a targeted 1-year protocol combining growth hormone, DHEA, and metformin regenerated thymic tissue and reversed participants' biological age by an average of 1.5 years on DNA methylation tests. This research highlights how combined endocrine and metabolic strategies can slow or reverse biological aging.
Reversal of epigenetic aging and immunosenescent trends in humans
Aging Cell · 2019 · Fahy GM et al.
As we age, our thymus gland—which produces disease-fighting T-cells—gradually shrinks and turns to fat, causing our immune system to weaken. In the historic TRIIM study, researchers used a combination therapy to successfully regrow functional thymic tissue, reverse immune system decline, and turn back human epigenetic age clocks by an average of 2.5 years. Restoring youthful immune defense is a major key to preventing disease and extending healthy lifespan.
Effects of tesamorelin on non-alcoholic fatty liver disease in HIV: a randomised, double-blind, multicentre trial
The Lancet HIV · 2019 · Stanley TL et al.
Deep visceral fat stored around abdominal organs and inside the liver is one of the most dangerous drivers of chronic disease and accelerated aging. This landmark trial showed that targeted growth hormone secretagogue therapy significantly decreased liver fat accumulation and prevented liver scarring. For longevity patients, reducing visceral fat through peptide therapy is a powerful way to enhance metabolic health, protect liver function, and reduce long-term cardiovascular risk.
Senolytics in idiopathic pulmonary fibrosis: Results from a first-in-human, open-label, pilot study
EBioMedicine · 2019 · Justice JN et al.
As we age, certain cells stop dividing but refuse to die, lingering in our tissues and releasing harmful inflammatory signals—earning them the nickname 'zombie cells.' This landmark clinical trial demonstrated that a short course of targeted natural and pharmaceutical compounds can selectively remove these cells in humans. Patients receiving the treatment experienced noticeable gains in mobility and physical performance, opening new doors for anti-aging therapies.
Inflammaging: a new immune-metabolic viewpoint for age-related diseases
Nature Reviews Endocrinology · 2018 · Franceschi C et al.
"Inflammaging" refers to the constant, low-grade internal inflammation that quietly develops as we get older, damaging healthy tissue and accelerating disease. This paper explains how factors like gut health, cellular stress, and immune fatigue trigger chronic inflammatory signals that fuel heart disease, diabetes, and memory loss. Identifying and resolving hidden sources of systemic inflammation is crucial for preserving lifelong health and vitality.
Association of Cardiorespiratory Fitness With Long-term Mortality Among Adults Undergoing Exercise Treadmill Testing
JAMA Network Open · 2018 · Mandsager K et al.
How well your heart and lungs deliver oxygen to your body during exercise—known as cardiorespiratory fitness or VO2 max—is one of the single best predictors of how long you will live. Studying over 120,000 individuals, researchers found that higher fitness levels drastically cut mortality risk, with no upper limit where exercise stopped being beneficial. Achieving elite aerobic fitness offers greater protection against premature death than quitting smoking or managing blood pressure.
TORC1 inhibition enhances immune function and reduces infections in the elderly
Science Translational Medicine · 2018 · Mannick JB et al.
Our immune system naturally weakens as we age, making us more vulnerable to seasonal infections and viruses. This clinical trial showed that low doses of a targeted compound that moderates the 'mTOR' cellular pathway could safely reboot immune function in older adults. Participants had significantly fewer infections over the following year and responded much better to vaccines, proving that age-related immune decline can be slowed or reversed.
Low-density lipoproteins cause atherosclerotic cardiovascular disease
European Heart Journal · 2017 · Ference BA et al.
Cardiovascular disease develops silently over decades as atherogenic particles accumulate inside artery walls. This landmark European consensus panel proved that atherogenic lipoproteins directly cause heart disease, and that total damage depends on cumulative lifelong exposure—much like 'pack-years' of smoking. Lowering your ApoB particle burden early in life protects your arteries and supports long-term cardiovascular health.
Importance of Assessing Cardiorespiratory Fitness in Clinical Practice: A Case for Fitness as a Clinical Vital Sign
Circulation · 2016 · Ross R et al.
Leading medical authorities now recognize cardiorespiratory fitness (VO2 max) as a vital sign just as critical as blood pressure or heart rate. Measuring how efficiently your body utilizes oxygen provides unmatched insight into your overall health, organ reserve, and cellular aging rate. Tracking and optimizing this metric allows individuals to take active, measurable control of their healthspan.
As we get older, our natural production of growth hormone gradually declines, contributing to loss of muscle mass, decreased energy, and slower recovery. This clinical study evaluated CJC-1295, a long-acting peptide that prompts the body's pituitary gland to naturally release its own growth hormone in a safe, balanced manner. By stimulating natural production rather than replacing it artificially, growth hormone secretagogues help restore youthful metabolic repair, lean body mass, and recovery.
We review emerging research and translate complex science into practical clinical insights you can actually use.
Put The Science To Work
Ready To Apply This Research To Your Own Health?
Dr. Christian translates emerging longevity science into personalized, physician-led care. Schedule a consultation to discuss what the evidence means for you.